These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8189599)
1. Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization. Mizutani Y; Bonavida B; Nio Y; Yoshida O J Urol; 1994 Jun; 151(6):1697-702. PubMed ID: 8189599 [TBL] [Abstract][Full Text] [Related]
2. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization. Mizutani Y; Yoshida O Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097 [TBL] [Abstract][Full Text] [Related]
3. Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha. Mizutani Y; Bonavida B Cancer; 1993 Aug; 72(3):809-18. PubMed ID: 8334635 [TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline enhances sensitivity of a human ovarian cancer cell line (OVC-8) to TNF-alpha. Mizutani Y; Bonavida B Biotherapy; 1993-1994; 7(2):109-14. PubMed ID: 7803190 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines. Mizutani Y; Bonavida B; Yoshida O Urol Res; 1994; 22(4):261-6. PubMed ID: 7871641 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistance. Safrit JT; Belldegrun A; Bonavida B J Urol; 1993 May; 149(5):1202-8. PubMed ID: 8483246 [TBL] [Abstract][Full Text] [Related]
7. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629 [TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline downregulates nitric oxide and tumor necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line. Park E; Schuller-Levis G; Park SY; Jia JH; Levis WR Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):225-33. PubMed ID: 11875767 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation. Weinberg JB; Mason SN; Wortham TS Blood; 1992 Jun; 79(12):3337-43. PubMed ID: 1596574 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797 [TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Neuner P; Klosner G; Schauer E; Pourmojib M; Macheiner W; Grünwald C; Knobler R; Schwarz A; Luger TA; Schwarz T Immunology; 1994 Oct; 83(2):262-7. PubMed ID: 7835945 [TBL] [Abstract][Full Text] [Related]
12. Effect of pentoxifylline on ischemic acute renal failure in rabbits. Kim YK; Yoo JH; Woo JS; Jung JS; Kim BS; Kim SY Ren Fail; 2001 Nov; 23(6):757-72. PubMed ID: 11777315 [TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Neuner P; Klosner G; Pourmojib M; Knobler R; Schwarz T Immunology; 1997 Mar; 90(3):435-9. PubMed ID: 9155652 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. D'Hellencourt CL; Diaw L; Cornillet P; Guenounou M Int J Immunopharmacol; 1996 Dec; 18(12):739-48. PubMed ID: 9172017 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Kim YK; Choi TR; Kwon CH; Kim JH; Woo JS; Jung JS Ren Fail; 2003 Nov; 25(6):909-22. PubMed ID: 14669850 [TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats. Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492 [TBL] [Abstract][Full Text] [Related]
17. Immune response modulation by pentoxifylline in vitro. Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance. Safrit JT; Bonavida B Cancer Res; 1992 Dec; 52(23):6630-7. PubMed ID: 1330298 [TBL] [Abstract][Full Text] [Related]
19. Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Rübe CE; Wilfert F; Uthe D; Schmid KW; Knoop R; Willich N; Schuck A; Rübe C Radiother Oncol; 2002 Aug; 64(2):177-87. PubMed ID: 12242128 [TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]